Ulceration of the leg is often associated with significant consequences for both the individual and society. The diagnosis of chronic leg ulcer is not appropriate. Primary cutaneous diffuse large B-cell lymphoma (PCLBCL), leg type, is a distinct clinicopathological entity. Chemotherapy in the form of R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, Oncovin and prednisolone) is considered to be the first line of treatment for these lymphomas. We report a 69-year-old man who presented with chronic leg ulcer with a first negative biopsy and a diagnosis of PCLBCL, leg type, verified on the subsequent biopsy. This case report emphasises the importance of differential diagnosis of lymphoma in non-healing ulcers and also the value of repeat tissue biopsy in cases with a negative initial result but strong clinical suspicion.
CITATION STYLE
Khan, J. A., Usman, F., Abbasi, S., & Shoab, S. S. (2011). Diffuse large B-cell lymphoma presenting as a chronic leg ulcer: The importance of repeat tissue biopsy. Annals of the Royal College of Surgeons of England, 93(4). https://doi.org/10.1308/003588411X13008889959172
Mendeley helps you to discover research relevant for your work.